MilliporeSigma - Gene Therapy

MilliporeSigma is skilled in the art of GMP viral vector production and technology innovation, having manufactured viral vectors for over 20 years and producing more than 500 lots of drug substance from preclinical through commercial production. Our comprehensive portfolio of best-in-class bioprocessing products and technologies combined with our application expertise can help you quickly scale up to reach your process goals. Our BioReliance^®​ testing services employ the broadest range of vector types to speed progress of gene therapy development.